| Document |
Document Title |
|
WO/2012/167346 |
The present invention relates to anti-ricin antibodies and uses thereof. More specifically, the invention relates to anti-ricin antibodies and fragments thereof as well as their use in therapy or prophylaxis.
|
|
WO/2012/167236 |
Provided are stable liquid and solid formulations of oxidized and reduced mitochondria-targeted antioxidants, and methods of their preparation and use.
|
|
WO/2012/163290 |
The present invention discloses a pharmaceutical polymer and a method for quenching free radicals. Said pharmaceutical polymer comprises a glycopeptides and an aminothiol moiety which covalently bonds together. The disclosed pharmaceutic...
|
|
WO/2012/159569 |
Provided in the present invention is an application for PRDX2 and/or PRDX6 in the preparation of a pharmaceutical composition to treat or prevent damage, aging or disease resulting from an increase in reactive oxygen species (ROS).
|
|
WO/2012/155061 |
A method of inhibiting, preventing, or reducing damage to non-cancerous cells in a human subject during chemotherapeutic treatment or radiation treatment of cancer cells in the human subject includes administering to the human subject ar...
|
|
WO/2012/150370 |
The present invention relates to a combination of the polyphenols resveratrol, quercetin and catechin in a molar ratio of approximately 1:1:2 or, alternatively, approximately 1:1:5, which has synergic antioxidant power. This combination ...
|
|
WO/2012/147901 |
The present invention provides a composition for mitigating anticancer drug side effects, the composition containing isoleucine, leucine and valine as active ingredients. The composition is extremely safe and moreover will not impact the...
|
|
WO/2012/146057 |
Disclosed is a curcuminoid injection solution mainly composed of curcuminoid, a solvent used for injection and a small amount of pH adjusting agent. Also provided is a curcuminoid intravenous injection which simply mixes the aforemention...
|
|
WO/2012/145307 |
In an embodiment, a barrier-forming composition includes a carbohydrate gum, a humectant, and an antimicrobial agent. The composition furthermore meets the following requirements: about 0.01% ≤ C ≤ about 0.4%; about 4.5% ≤ H ≤ ab...
|
|
WO/2012/138713 |
The present disclosure provides methods for identifying therapeutic agents that are multifunctional radical quenchers. It also provides compounds of formula (I), (II), or (II-A): and pharmaceutically acceptable salts thereof, composition...
|
|
WO/2012/138806 |
There are provided fractions of olive mill waste. Method of preparing the fractions and uses thereof are also described.
|
|
WO/2012/138713 |
The present disclosure provides methods for identifying therapeutic agents that are multifunctional radical quenchers. It also provides compounds of formula (I), (II), or (II-A): and pharmaceutically acceptable salts thereof, composition...
|
|
WO/2012/130834 |
The present invention relates to antibody molecules against anticoagulants, in particular dabigatran,and their use as antidotes of such anticoagulants.
|
|
WO/2012/129942 |
Disclosed are a chiral 3-hydroxypyrid-4-one derivative and a salt thereof. The compound is acquired by reacting methyl maltol or ethyl maltol with benzyl chloride to acquire a 3-benzyl protected maltol, then by reacting compound VII with...
|
|
WO/2012/126047 |
The invention provides a method of treating pain, reducing inflammation and reducing skin irritation particularly itching, the method comprising administering a polypeptide comprising thymosin, or an active fragment or variant thereof or...
|
|
WO/2012/121150 |
Provided is a gene that is useful for imparting hydrogen peroxide resistance to a microorganism. Also provided is a method for using the same. The hydrogen peroxide resistance-imparting gene encodes a protein selected from the following ...
|
|
WO/2012/116577 |
The present invention relates to a compound of the following general formula (I) which has strong anti-oxidization activity, the preparation process thereof, an intermediate used, a composition and medical preparation comprising the comp...
|
|
WO/2012/111187 |
[Problem] To provide a medicine, cosmetic and supplement comprising food constituents or nutrients which have been used extensively as food and are safe, and having skin collagen production promoting effects. [Solution] The skin collagen...
|
|
WO/2012/109662 |
Methods are disclosed to create healthier palm oil and new food additives derived from products of the processing of Elaeis fruit that were hitherto fore discarded as waste. The pressing product of Elaeis fruit and the effluent created i...
|
|
WO/2012/109662 |
Methods are disclosed to create healthier palm oil and new food additives derived from products of the processing of Elaeis fruit that were hitherto fore discarded as waste. The pressing product of Elaeis fruit and the effluent created i...
|
|
WO/2012/107211 |
The invention is directed to the treatment of prostate cancer by means of antibodies. Above all, the invention relates to the administration of an anti-alpha-v integrin (receptor) antibody to patients suffering from prostate cancer, espe...
|
|
WO/2012/103637 |
The present invention provides compositions having synergistic antioxidant properties in the modulation of Toll-like receptor signaling for the promotion of homeostasis, immunity, energy conservation, protection of neural cells and anti-...
|
|
WO/2012/097577 |
Provided are a pharmaceutical composition for relieving fatigue and a preparation method therefor. The pharmaceutical composition is acquired by mixing a ginseng ethanolic extract, an astragalus ethanolic extract, an epimedium ethanolic ...
|
|
WO/2012/097420 |
Pharmaceutical composition for treating oxidative stress-induced pathology, comprising a combination of the active principles methionine, cysteine and phenylalanine combined with at least one pharmaceutical excipient; said active princip...
|
|
WO/2012/096183 |
Disclosed is a water-insoluble polymeric iron chelating agent characterized by having a polymer backbone and an aromatic ring which is bound to the polymer backbone through a bond -NH-CH2-, wherein the aromatic ring has one or two first ...
|
|
WO/2012/095509 |
The present invention refers to a liquid composition comprising Vitamin C, L-glutamine and/or L-glutamic acid, L-cysteine and/or L-cystine, riboflavin, succinic acid, fumaric acid, coenzyme Q 10, niacin and hydrogen carbonate, phosphate ...
|
|
WO/2012/095509 |
The present invention refers to a liquid composition comprising Vitamin C, L-glutamine and/or L-glutamic acid, L-cysteine and/or L-cystine, riboflavin, succinic acid, fumaric acid, coenzyme Q 10, niacin and hydrogen carbonate, phosphate ...
|
|
WO/2012/093738 |
The present invention relates to a composition for combating oxidation and alleviating the detrimental effects on skin caused by Asian Dust, the composition containing Melia azedarach bark and Nelumbo nucifera leaf extracts as a novel sk...
|
|
WO/2012/092157 |
Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children ...
|
|
WO/2012/092158 |
Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
|
|
WO/2012/092157 |
Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children ...
|
|
WO/2012/092156 |
Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk olig...
|
|
WO/2012/092159 |
Disclosed are methods of reducing the incidence of oxidative stress in infants, toddlers, and children using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosacch...
|
|
WO/2012/080982 |
The invention concerns a functional food preparation based on milk / dairy products added with botanical products containing various active principles. The milk / dairy products, which can be obtained from fresh or pasteurized animal mil...
|
|
WO/2012/080982 |
The invention concerns a functional food preparation based on milk / dairy products added with botanical products containing various active principles. The milk / dairy products, which can be obtained from fresh or pasteurized animal mil...
|
|
WO/2012/080982 |
The invention concerns a functional food preparation based on milk / dairy products added with botanical products containing various active principles. The milk / dairy products, which can be obtained from fresh or pasteurized animal mil...
|
|
WO/2012/077108 |
The present invention provides multifunctional nitroxide derivatives comprising a potassium channel opener and a reactive oxygen species (ROS) degradation catalyst that can act as an anti-oxidant, as well as pharmaceutical compositions c...
|
|
WO/2012/071772 |
A grape wine made from grape seed, grape bark, Bark of Masson Pine, apple, orange endothelium, Flower of Aztec Marigold, Mulberry Fruit, blueberry, Cowberry Fruit, is disclosed.
|
|
WO/2012/064230 |
A sorbent selected from a group of reversed-phase liquid chromatography sorbents is proposed as a digestive tract detoxicant for vertebrates, said sorbent being a hydrophobizated matrix of polysilicic acid gel having the general approxim...
|
|
WO/2012/061931 |
The present invention relates to the use of a natural compound in diabetes prevention. More specifically, the invention relates to the use of geniposide as a pancreatic beta cell protectant for diabetes prevention and treatment.
|
|
WO/2012/063973 |
The present invention provides an antioxidant composition having a superior antioxidative effect: an antioxidant composition comprising oxidized glutathione.
|
|
WO/2012/057635 |
The invention provides a method of treating traumatic brain injury (TBI) by administering a composition comprising proanthocyanidins. The proanthocyanidins are preferably administered as an extract of pine bark that contains proanthocyan...
|
|
WO/2012/057343 |
Disclosed is an NAD(P)H oxidase inhibitor which contains a substance that activates a glucagon-like peptide receptor or a pharmaceutically acceptable salt of the substance. The substance may be a glucagon-like peptide, a derivative of a ...
|
|
WO/2012/055090 |
A drink for supplementing energy and recovering from fatigue containing glucose-6-phosphate, its preparing method and utility are disclosed herein. The method is as following: mixing glucose, ATP and MgCl2, catalysing by hexokinase, thus...
|
|
WO/2012/054988 |
The present invention relates to compounds and compositions useful as antioxidants and in particular to selenium containing compounds of formula (I): wherein n is 1, 2, or 3; m is 2, 3, 4, or 5; and each R] is independently -(optionally ...
|
|
WO/2012/050425 |
This present invention relates to a process for extracting and recovering of water soluble compounds with anti-oxidative properties from oil palm biomass such as oil palm leaves, palm pressed fibre and empty fruit bunches. The process ca...
|
|
WO/2012/050025 |
[Problem] To provide a medical adsorbent for oral administration that has excellent adsorption capacity and selective adsorption of toxins that are to be removed, even at low doses, and that is economical and minimizes environmental impa...
|
|
WO/2012/050425 |
This present invention relates to a process for extracting and recovering of water soluble compounds with anti-oxidative properties from oil palm biomass such as oil palm leaves, palm pressed fibre and empty fruit bunches. The process ca...
|
|
WO/2012/043577 |
The problem addressed by the present invention is the provision of: a reversing agent that reverses the anticoagulant effects of an FXa inhibitor; and/or a reversal method using said reversing agent. [Solution] A reversing agent for an o...
|
|
WO/2012/037466 |
Described are methods for preventing or inhibiting genomic instability and in cells affected by diagnostic radiology procedures employing ionizing radiation. Embodiments include methods of preventing or inhibiting genomic instability and...
|
